TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MYGN

Myriad Genetics Inc

Healthcare · Diagnostics & Research

4.20$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MYGN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.43 1.89 2.27 1.54 1.61 1.10 1.12 0.24 -1.32 -1.34 -0.10 0.02
0.18 0.34 0.37 0.70 0.76 0.96 0.98 0.81 0.65 0.75 0.68 0.58
0.35 0.61 0.43 0.43 0.38 0.44 0.45 0.47 0.47 0.49 0.55 0.38
– – – – – – 0.95 – – – – –
-0.77 -0.55 -0.72 0.08 0.12 -0.52 -0.50 1.55 -1.04 0.33 -0.60 -0.21
0.18 0.32 0.07 0.09 0.12 0.11 0.12 0.23 0.56 0.89 0.33 0.29
-0.22 0.55 -1.25 -2.13 -0.16 -3.77 0.26 3.52 -0.96 0.39 -0.13 -0.29
– – – 5.86 – 4.47 4.55 – – – – –
-3.68 -2.83 -2.22 -0.46 – -0.66 -0.67 0.00 – – – –
– – – – – – – -2.90 0.00 0.48 0.00 0.90
-2.71 -2.38 -0.93 1.04 -1.32 2.40 2.44 -1.93 -0.10 1.85 -0.08 0.69
-0.50 -0.01 0.06 0.49 0.12 -0.23 -0.24 1.82 -2.39 0.90 -0.32 0.42
2.25 1.57 2.20 1.45 1.49 0.99 1.00 0.01 -1.88 -2.22 -0.42 -0.27

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?